ML
Moolec Science S.A.
MLEC · NASDAQ
$5.55 +0.54% (+$0.03)
1M -22.21%
Market Cap $4.52M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/S 0.01x
P/E N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
13 /100
Weak Gross margin 34.17%
Net margin 33.41%
Op. margin 3.14%
Quality
21 /100
Poor ROIC 5.56%
ROA 54.45%
Asset turnover 1.63x
Debt
0 /100
High Current ratio 0.13x
Int. coverage -2.18x
Debt/Equity N/A
Stability
6 /100
Unstable Beta 0.26x
EPS volatility 4,916.31%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o MLEC
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Alejandro Antalich
Employees
103
Headquarters
Grand Cayman